Int J Womens Health. 2018 Feb 26;10:109-115. doi: 10.2147/IJWH.S125784. eCollection 2018.
Pustular psoriasis of pregnancy: current perspectives.
International journal of women's health
Megha K Trivedi, Alexandra R Vaughn, Jenny E Murase
Affiliations
Affiliations
- Department of Dermatology, University of California, San Francisco, CA, USA.
- Medical School, University of Michigan, Ann Arbor, MI, USA.
- College of Medicine, Drexel University, Philadelphia, PA, USA.
- Department of Dermatology, Palo Alto Medical Foundation, Palo Alto, CA, USA.
PMID: 29520163
PMCID: PMC5834178 DOI: 10.2147/IJWH.S125784
Abstract
Pustular psoriasis of pregnancy (PPP) is a life-threatening condition for both the pregnant mother and fetus, and must be efficiently and accurately diagnosed and treated. This condition has historically been classified as a unique, separate dermatosis of pregnancy. However, current opinion and data suggest that it may be a variant of generalized pustular psoriasis. PPP typically occurs in the third trimester and is characterized by widespread coalescent pustules, desquamation, and systemic symptoms. Clinical features and histopathologic evaluation aid in diagnosis. Treatments during pregnancy include high-dose corticosteroids, cyclosporine, narrow-band ultraviolet B radiation, infliximab, granulocyte and monocyte adsorptive apheresis, and systemic antibiotics. Both the mother and fetus should be closely monitored with appropriate laboratory studies for the duration of the pregnancy and postpartum.
Keywords: dermatoses of pregnancy; generalized pustular psoriasis; impetigo herpetiformis; pustular psoriasis of pregnancy
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
- Dermatology. 2011;222(3):221-4 - PubMed
- Am J Ther. 2016 Sep-Oct;23 (5):e1250-2 - PubMed
- Clin Exp Dermatol. 2009 Jun;34(4):521-2 - PubMed
- Dermatology. 1999;198(1):61-4 - PubMed
- Indian J Dermatol. 2016 Jan-Feb;61(1):123 - PubMed
- Obstet Gynecol. 1984 Sep;64(3 Suppl):49S-51S - PubMed
- J Eur Acad Dermatol Venereol. 2009 Mar;23(3):336-7 - PubMed
- Clin Dermatol. 2006 Mar-Apr;24(2):101-4 - PubMed
- Am J Gastroenterol. 2004 Dec;99(12):2385-92 - PubMed
- J Allergy Clin Immunol. 2017 Jul;140(1):109-120 - PubMed
- Acta Derm Venereol. 2017 Mar 10;97(3):410-411 - PubMed
- Br J Dermatol. 1997 Jul;137(1):123-9 - PubMed
- Dermatol Ther. 2013 Jul-Aug;26(4):274-84 - PubMed
- Indian J Dermatol. 2010 Apr-Jun;55(2):181-4 - PubMed
- An Bras Dermatol. 2013 Nov-Dec;88(6 Suppl 1):186-9 - PubMed
- Acta Derm Venereol. 2013 Jan;93(1):102-3 - PubMed
- Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):638 - PubMed
- Dermatology. 2013;226(1):35-40 - PubMed
- Int J Dermatol. 2015 Feb;54(2):e60-2 - PubMed
- BMJ Case Rep. 2011 May 12;2011:null - PubMed
- J Dermatol Sci. 2017 Jan;85(1):58-60 - PubMed
- Eur J Anaesthesiol. 2009 May;26(5):441-3 - PubMed
- J Obstet Gynaecol Res. 2015 Feb;41(2):301-3 - PubMed
- Cases J. 2009 Dec 16;2:9338 - PubMed
- J Obstet Gynaecol Res. 2011 Jun;37(6):661-3 - PubMed
- Arch Dermatol Res. 2016 Jan;308(1):55-63 - PubMed
- Clin Dermatol. 2016 May-Jun;34(3):335-43 - PubMed
- Clin Dermatol. 2016 May-Jun;34(3):314-9 - PubMed
- Dermatology. 2010;220(1):71-6 - PubMed
- Dermatol Ther. 2014 May-Jun;27(3):174-7 - PubMed
- J Dermatol. 2016 Dec;43(12 ):1439-1440 - PubMed
- Br J Dermatol. 1982 Aug;107(2):253 - PubMed
- Cutan Ocul Toxicol. 2012 Mar;31(1):67-9 - PubMed
- Int J Dermatol. 2009 Mar;48(3):299-303 - PubMed
- J Dermatol Sci. 2015 Sep;79(3):319-20 - PubMed
- Obstet Med. 2016 Jun;9(2):55-9 - PubMed
- Arch Dermatol Res. 2003 Apr;295 Suppl 1:S43-54 - PubMed
- J Am Acad Dermatol. 2012 Aug;67(2):279-88 - PubMed
- Arch Dermatol. 1982 Feb;118(2):103-5 - PubMed
- Case Rep Dermatol. 2013 Mar 23;5(1):99-104 - PubMed
- Am J Hum Genet. 2011 Sep 9;89(3):432-7 - PubMed
- J Dermatol. 2001 Jun;28(6):335-7 - PubMed
Publication Types